A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants with Huntington¿s Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Sage Therapeutics
Start Date
March 3, 2022
End Date
December 31, 2024
Administered By
Neurology, Movement Disorders
Awarded By
Sage Therapeutics
Start Date
March 3, 2022
End Date
December 31, 2024